# Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct05776524/  
OnCo record `nct05776524` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by THERABIONIC INC., now recruiting.

## Summary

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT05776524 by THERABIONIC INC., with a registry enrolment figure of 46 participants, started 2023-06-13 and due to reach its primary completion in 2027-07. Interventions recorded: Nab paclitaxel; Gemcitabine; TheraBionic. Conditions listed: Pancreatic Cancer; Metastatic Adenocarcinoma. Primary outcome: Overall Survival. Pancreatic eligibility wording from the registry: "* Patient must have newly diagnosed untreated biopsy proven metastatic adenocarcinoma of the pancreas". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT05776524
- Phase: 2
- Setting: A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
- Sponsor: THERABIONIC INC.
- Enrolled: 46

## Sources

- ClinicalTrials.gov NCT05776524: https://clinicaltrials.gov/study/NCT05776524

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05776524.json